VIEKIRA PAK associated drug-induced interstitial lung disease: Case series with systematic review of literature

참고문헌 (15)

1. Ferenci P, "ABT-450", r-ombitasvir and dasabuvir with or without ribavarin for HCV, 2014, pp.370, 1983~1992
2. Feld JJ, "Treatment of HCV with ABT-450", r-ombitasvir and dasabuvir with ribavarin, 2014, pp.370, 1594~1603
3. Poordad F, "ABT-450", r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis, 2014, pp.370, 1973~1982
4. Zeuzem S, "Retreatment of HCV with ABT-450", r-ombitasvir and dasabuvir with ribavarin, 2014, pp.370, 1604~1614
5. European Association for the Study of the Liver, "EASL recommendation on treatment of hepatitis C 2016", J Hepatol, 66, pp.153~194 (2017)
6. AASLD, "IDSA HCV Guidance Panel", Hepatitis C guidance: AASLDIDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus, 2015, pp.62, 932~954
7. "VIEKIRA PAK"[URL]
8. "New Zealand data sheet"[URL]
9. Abdalla DA, "Respiratory adverse effects of sofosbuvir-based regimens for treatment of chronic hepatitis C virus", Egypt J Chest Dis Tuberc, 66, pp.363~367 (2017)
10. Tamaki K, "Simeprevir with peginterferon and ribavirin induced interstitial pneumonitis : first case report", World J Gastroenterol, 21, pp.1009~1013 (2015)
11. Helmers RA, "Serious pulmonary toxicity secondary to novel hepatitis C antiviral therapy in a liver transplant recipient", Mayo Clin Proc, 90, pp.1294~1297 (2015)
12. Slavenburg S, "Pneumonitis as a consequence of(peg)interferon-ribavirin combination therapy for hepatitis C : a review of the literature", Dig Dis Sci, 55, pp.579~585 (2010)
13. Torres-Macho J, "Pegylated interferon induced interstitial pneumonitis in a patient with hepatitis C infection", Rev Esp Enferm Dig, 102, pp.606~608 (2010)
14. Wu SY, "Drug induced pneumonitis secondary to treatment with paritaprevir", ritonavir, Case Rep Med, pp.2017, 2017[DOI]
15. Tarao K, "A hepatitis C-virus-associated cirrhotic patient developing interstitial pneumonia during the course of antiviral therapy with ombitasvir", paritaprevir, Case Rep Gastroenterol, pp.2017, 11[DOI]

관련 논문AI추천